Author: Reese David Nabholtz Jean-Marc
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.3, Iss.9, 2002-09, pp. : 1329-1339
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anastrozole: In Early Breast Cancer
Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. :
Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer
By Nabholtz Jean-Marc Mouret-Reynier Marie-Ange Durando Xavier Van Praagh Isabelle Al-Sukhun Sana Ferriere Jean-Pierre Chollet Philippe
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. :
5 years' anastrozole superior to tamoxifen in breast cancer
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
Switch to anastrozole benefits QOL in breast cancer
Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. :